TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,934,853 | +84.3% | 1,561,092 | 0.0% | 0.05% | +74.2% |
| Q4 2022 | $1,592,314 | -61.2% | 1,561,092 | 0.0% | 0.03% | -61.7% |
| Q3 2022 | $4,106,000 | -41.7% | 1,561,092 | 0.0% | 0.08% | -46.4% |
| Q2 2022 | $7,041,000 | -54.2% | 1,561,092 | 0.0% | 0.15% | -37.3% |
| Q1 2022 | $15,361,000 | -35.6% | 1,561,092 | 0.0% | 0.24% | -21.0% |
| Q4 2021 | $23,869,000 | +15.4% | 1,561,092 | 0.0% | 0.30% | +11.7% |
| Q3 2021 | $20,686,000 | -7.7% | 1,561,092 | 0.0% | 0.27% | -9.3% |
| Q2 2021 | $22,411,000 | – | 1,561,092 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $8,915,122 | 9.37% |
| BML Capital Management, LLC | 2,000,000 | $6,080,000 | 5.47% |
| Acuitas Investments, LLC | 491,141 | $1,493,069 | 0.87% |
| SCOGGIN MANAGEMENT LP | 289,608 | $880,408 | 0.57% |
| Nantahala Capital Management | 1,450,034 | $4,408,103 | 0.43% |
| GREAT POINT PARTNERS LLC | 666,033 | $2,024,740 | 0.40% |
| Affinity Asset Advisors, LLC | 200,000 | $608,000 | 0.21% |
| RA Capital Management | 2,333,175 | $7,092,852 | 0.13% |
| Blackstone Inc. | 8,089,315 | $24,591,518 | 0.10% |
| QVT Financial LP | 589,314 | $1,791,515 | 0.10% |